Iron supplementation affects growth and morbidity of breast-fed infants: Results of a randomized trial in Sweden and Honduras

Kathryn G. Dewey, Magnus Domellöf, Roberta J. Cohen, Leonardo Landa Rivera, Olle Hernell, Bo Lönnerdal

Research output: Contribution to journalArticle

189 Citations (Scopus)

Abstract

Iron supplements are often prescribed during infancy but their benefits and risks have not been well documented. We examined whether iron supplements affect growth or morbidity of breast-fed infants. Full-term infants in Sweden (n = 101) and Honduras (n = 131) were randomly assigned to three groups at 4 mo of age: 1) placebo from 4 to 9 mo; 2) placebo from 4 to 6 mo and iron supplements [1 mg/(kg · d)] from 6 to 9 mo; or 3) iron supplements from 4 to 9 mo. All infants were exclusively or nearly exclusively breast-fed to 6 mo and continued to be breast-fed to at least 9 mo. Growth was measured monthly and morbidity data were collected every 2 wk. Among the Swedish infants, gains in length and head circumference were significantly lower in those who received iron than in those given placebo from 4 to 9 mo. The same effect on length was seen in Honduras, but only at 4-6 mo among those with initial hemoglobin (Hb) ≥110 g/L. There was no significant main effect of iron supplementation on morbidity, nor any significant interaction between iron supplementation and site, but for diarrhea (with both sites combined), there was an interaction between iron supplementation and initial Hb. Among infants with Hb < 110 g/L at 4 mo, diarrhea was less common among those given iron than in those given placebo from 4-9 mo, whereas the opposite was true among those with Hb ≥ 110 g/L (P < 0.05). We conclude that routine iron supplementation of breast-fed infants may benefit those with low Hb but may present risks for those with normal Hb.

Original languageEnglish (US)
Pages (from-to)3249-3255
Number of pages7
JournalJournal of Nutrition
Volume132
Issue number11
StatePublished - Nov 1 2002

Fingerprint

Honduras
Sweden
breasts
morbidity
Breast
Iron
iron
Morbidity
Growth
hemoglobin
Hemoglobins
placebos
Placebos
Diarrhea
diarrhea
head circumference
infancy
Head

Keywords

  • Anemia
  • Breast-feeding
  • Diarrhea
  • Infant growth
  • Iron supplementation

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Food Science

Cite this

Dewey, K. G., Domellöf, M., Cohen, R. J., Rivera, L. L., Hernell, O., & Lönnerdal, B. (2002). Iron supplementation affects growth and morbidity of breast-fed infants: Results of a randomized trial in Sweden and Honduras. Journal of Nutrition, 132(11), 3249-3255.

Iron supplementation affects growth and morbidity of breast-fed infants : Results of a randomized trial in Sweden and Honduras. / Dewey, Kathryn G.; Domellöf, Magnus; Cohen, Roberta J.; Rivera, Leonardo Landa; Hernell, Olle; Lönnerdal, Bo.

In: Journal of Nutrition, Vol. 132, No. 11, 01.11.2002, p. 3249-3255.

Research output: Contribution to journalArticle

Dewey, KG, Domellöf, M, Cohen, RJ, Rivera, LL, Hernell, O & Lönnerdal, B 2002, 'Iron supplementation affects growth and morbidity of breast-fed infants: Results of a randomized trial in Sweden and Honduras', Journal of Nutrition, vol. 132, no. 11, pp. 3249-3255.
Dewey KG, Domellöf M, Cohen RJ, Rivera LL, Hernell O, Lönnerdal B. Iron supplementation affects growth and morbidity of breast-fed infants: Results of a randomized trial in Sweden and Honduras. Journal of Nutrition. 2002 Nov 1;132(11):3249-3255.
Dewey, Kathryn G. ; Domellöf, Magnus ; Cohen, Roberta J. ; Rivera, Leonardo Landa ; Hernell, Olle ; Lönnerdal, Bo. / Iron supplementation affects growth and morbidity of breast-fed infants : Results of a randomized trial in Sweden and Honduras. In: Journal of Nutrition. 2002 ; Vol. 132, No. 11. pp. 3249-3255.
@article{a48bf24ac04a4691b210545baef58305,
title = "Iron supplementation affects growth and morbidity of breast-fed infants: Results of a randomized trial in Sweden and Honduras",
abstract = "Iron supplements are often prescribed during infancy but their benefits and risks have not been well documented. We examined whether iron supplements affect growth or morbidity of breast-fed infants. Full-term infants in Sweden (n = 101) and Honduras (n = 131) were randomly assigned to three groups at 4 mo of age: 1) placebo from 4 to 9 mo; 2) placebo from 4 to 6 mo and iron supplements [1 mg/(kg · d)] from 6 to 9 mo; or 3) iron supplements from 4 to 9 mo. All infants were exclusively or nearly exclusively breast-fed to 6 mo and continued to be breast-fed to at least 9 mo. Growth was measured monthly and morbidity data were collected every 2 wk. Among the Swedish infants, gains in length and head circumference were significantly lower in those who received iron than in those given placebo from 4 to 9 mo. The same effect on length was seen in Honduras, but only at 4-6 mo among those with initial hemoglobin (Hb) ≥110 g/L. There was no significant main effect of iron supplementation on morbidity, nor any significant interaction between iron supplementation and site, but for diarrhea (with both sites combined), there was an interaction between iron supplementation and initial Hb. Among infants with Hb < 110 g/L at 4 mo, diarrhea was less common among those given iron than in those given placebo from 4-9 mo, whereas the opposite was true among those with Hb ≥ 110 g/L (P < 0.05). We conclude that routine iron supplementation of breast-fed infants may benefit those with low Hb but may present risks for those with normal Hb.",
keywords = "Anemia, Breast-feeding, Diarrhea, Infant growth, Iron supplementation",
author = "Dewey, {Kathryn G.} and Magnus Domell{\"o}f and Cohen, {Roberta J.} and Rivera, {Leonardo Landa} and Olle Hernell and Bo L{\"o}nnerdal",
year = "2002",
month = "11",
day = "1",
language = "English (US)",
volume = "132",
pages = "3249--3255",
journal = "Journal of Nutrition",
issn = "0022-3166",
publisher = "American Society for Nutrition",
number = "11",

}

TY - JOUR

T1 - Iron supplementation affects growth and morbidity of breast-fed infants

T2 - Results of a randomized trial in Sweden and Honduras

AU - Dewey, Kathryn G.

AU - Domellöf, Magnus

AU - Cohen, Roberta J.

AU - Rivera, Leonardo Landa

AU - Hernell, Olle

AU - Lönnerdal, Bo

PY - 2002/11/1

Y1 - 2002/11/1

N2 - Iron supplements are often prescribed during infancy but their benefits and risks have not been well documented. We examined whether iron supplements affect growth or morbidity of breast-fed infants. Full-term infants in Sweden (n = 101) and Honduras (n = 131) were randomly assigned to three groups at 4 mo of age: 1) placebo from 4 to 9 mo; 2) placebo from 4 to 6 mo and iron supplements [1 mg/(kg · d)] from 6 to 9 mo; or 3) iron supplements from 4 to 9 mo. All infants were exclusively or nearly exclusively breast-fed to 6 mo and continued to be breast-fed to at least 9 mo. Growth was measured monthly and morbidity data were collected every 2 wk. Among the Swedish infants, gains in length and head circumference were significantly lower in those who received iron than in those given placebo from 4 to 9 mo. The same effect on length was seen in Honduras, but only at 4-6 mo among those with initial hemoglobin (Hb) ≥110 g/L. There was no significant main effect of iron supplementation on morbidity, nor any significant interaction between iron supplementation and site, but for diarrhea (with both sites combined), there was an interaction between iron supplementation and initial Hb. Among infants with Hb < 110 g/L at 4 mo, diarrhea was less common among those given iron than in those given placebo from 4-9 mo, whereas the opposite was true among those with Hb ≥ 110 g/L (P < 0.05). We conclude that routine iron supplementation of breast-fed infants may benefit those with low Hb but may present risks for those with normal Hb.

AB - Iron supplements are often prescribed during infancy but their benefits and risks have not been well documented. We examined whether iron supplements affect growth or morbidity of breast-fed infants. Full-term infants in Sweden (n = 101) and Honduras (n = 131) were randomly assigned to three groups at 4 mo of age: 1) placebo from 4 to 9 mo; 2) placebo from 4 to 6 mo and iron supplements [1 mg/(kg · d)] from 6 to 9 mo; or 3) iron supplements from 4 to 9 mo. All infants were exclusively or nearly exclusively breast-fed to 6 mo and continued to be breast-fed to at least 9 mo. Growth was measured monthly and morbidity data were collected every 2 wk. Among the Swedish infants, gains in length and head circumference were significantly lower in those who received iron than in those given placebo from 4 to 9 mo. The same effect on length was seen in Honduras, but only at 4-6 mo among those with initial hemoglobin (Hb) ≥110 g/L. There was no significant main effect of iron supplementation on morbidity, nor any significant interaction between iron supplementation and site, but for diarrhea (with both sites combined), there was an interaction between iron supplementation and initial Hb. Among infants with Hb < 110 g/L at 4 mo, diarrhea was less common among those given iron than in those given placebo from 4-9 mo, whereas the opposite was true among those with Hb ≥ 110 g/L (P < 0.05). We conclude that routine iron supplementation of breast-fed infants may benefit those with low Hb but may present risks for those with normal Hb.

KW - Anemia

KW - Breast-feeding

KW - Diarrhea

KW - Infant growth

KW - Iron supplementation

UR - http://www.scopus.com/inward/record.url?scp=0036846243&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036846243&partnerID=8YFLogxK

M3 - Article

C2 - 12421836

AN - SCOPUS:0036846243

VL - 132

SP - 3249

EP - 3255

JO - Journal of Nutrition

JF - Journal of Nutrition

SN - 0022-3166

IS - 11

ER -